Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Stokes GS – The prime objective of this therapy is to prevent stroke. The findings of controlled trials show that there should be no cut–off age for treatment. A holistic program for controlling cardiovascular risks should be fully discussed with the patient, including evaluation to exclude underlying causes of secondary hypertension, and implementation of lifestyle measures. The choice of antihypertensive drug therapy is influenced by concomitant disease and previous medication history, but will typically include a thiazide diuretic as the first–line agent; to this will be added an angiotensin inhibitor and/or a calcium channel blocker. Beta blockers are not generally recommended, in part because they do not combat the effects of increased arterial stiffness. The hypertension–hypotension syndrome requires case–specific management. Drug–resistant hypertension is important to differentiate from faulty compliance with medication. Patients resistant to third–line drug therapy may benefit from treatment with extended–release isosorbide mononitrate. A trial of spironolactone may also be worthwhile.

Related Articles

Practical strategies for management of hypertension in the elderly
Geriatrics, 10/21/09    Relevance Score: 67%

Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09    Relevance Score: 67%

Relation of Consistency With the Dietary Approaches to Stop Hypertension Diet and Incidence of Heart Failure in Men Aged 45 to 79 Years
The American Journal of Cardiology, 11/10/09    Relevance Score: 66%

Hypertension Common in Children of Alzheimers Patients
Ivanhoe, 11/09/09    Relevance Score: 65%

Serum Estrogen Metabolites and Systolic Blood Pressure Among Middle-Aged and Older Women and Men
American Journal of Hypertension, 10/28/09    Relevance Score: 65%

Today in Cardiac/Hypertension...keeping you current

Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09

Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09

Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address